Pancreatic Cancer Research

ResearcherJiaxing UniversityActive in the last 2 years

Xiaoguang Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5134479153. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 5

  1. FBXO22-mediated ubiquitination of KLF10 promoting pancreatic cancer proliferation and invasion. Last author DOI 10.1016/j.pan.2025.11.016↗
  2. Human Pancreatic Cancer Organoids. Co-author DOI 10.1111/cpr.70210↗
  3. The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis. Last author DOI 10.1186/s12876-024-03581-5↗
  4. Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy. Co-author DOI 10.3389/fimmu.2025.1578870↗
  5. Apolipoprotein E is a prognostic factor for pancreatic cancer and associates with immune infiltration. Last author DOI 10.1016/j.cyto.2024.156628↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaorong Liu · 2 shared papers, 2025–2026 · strength 0.66
  2. Zhengwei Song · 2 shared papers, 2024–2025 · strength 0.51
  3. Fenfen Jiang · 1 shared paper, 2026 · strength 0.36
  4. Lingyu Hu · 1 shared paper, 2025 · strength 0.30
  5. Wei Guo · 1 shared paper, 2025 · strength 0.30
  6. Bin Wu · 1 shared paper, 2024 · strength 0.26
  7. Fei Chen · 1 shared paper, 2024 · strength 0.26
  8. Siqi Zhao · 1 shared paper, 2025 · strength 0.26
  9. Lingyu Hu · 1 shared paper, 2025 · strength 0.26
  10. Xianming Kong · 1 shared paper, 2026 · strength 0.18
  11. Aina He · 1 shared paper, 2026 · strength 0.18
  12. Ting Han · 1 shared paper, 2026 · strength 0.18
  13. Zunqiang Zhou · 1 shared paper, 2026 · strength 0.18
  14. Chunyan Dong · 1 shared paper, 2026 · strength 0.18
  15. Dongxi Xiang · 1 shared paper, 2026 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.